Skip to main content

Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays.

Lukasz A, Hellpap J, Horn R, Kielstein JT, David S, Haller H, Kümpers P

Publication: Crit Care (2008) • Vol 12 • Page R94PMID: 18664247View on PubMedSuggested by: ISBER

Purpose

The purpose of this paper was to determine the effects of patient characteristics and treatments, storage, and assay type on angiopoietin-1 (Ang-1) and Ang-2 levels in plasma and serum specimens.

Conclusion

Ang-1 levels were highly correlated between immunoluminometric (ILMA) and immunoradiometric (IRMA) assays. In contrast to the easily detectable levels found in serum, Ang-1 was hardly detectable in EDTA-plasma, even when a calcium supplemented buffer was used. Ang-2 was also lower in EDTA-plasma than in serum, but this difference could be eliminated by using a calcium supplemented buffer. Storage of serum for 24 h at room temperature or 4 degrees C and through up to 4 freeze-thaw cycles did not change Ang-1 or Ang-2 levels. In healthy individuals, Ang-1 and Ang-2 levels in serum did not correlate with age, body mass index, glomerular filtration rate, or serum creatinine, but Ang-1 levels were slightly higher in women than men. In critical care patients, Ang-1 levels were weakly, inversely correlated with the severity of the illness as determined by sequential organ failure assessment (SOFA) scores, while ANG-2 levels were weakly, positively correlated. However, in critical care patients, neither protein was correlated with age or gender. Ang-2 levels showed more variability over the course of 24 h than Ang-1. Antibiotics did not affect Ang-1 or Ang-2 levels, but dialysis decreased Ang-1 and Ang-2 levels by 36.2 and 23.1%, respectively.

Studies (1)

Purpose

The purpose of this study was to determine the effects of patient characteristics and treatments, storage, and assay type on Ang-1 and Ang-2 levels in plasma and serum specimens.

Summary of Findings

Ang-1 levels were highly correlated between ILMA and IRMA (r=0.95). In contrast to the readily detectable levels found in serum, Ang-1 was hardly detectable in EDTA-plasma, even when a calcium supplemented buffer was used. Ang-2 was 20% lower in EDTA-plasma than in serum, but this difference could be eliminated by using a calcium supplemented buffer. Storage of serum for 24 h at room temperature or 4 degrees C and through 4 freeze-thaw cycles did not change Ang-1 or Ang-2 levels. In healthy individuals, Ang-1 and Ang-2 levels in serum did not correlate with age, body mass index, glomerular filtration rate, or serum creatinine, but Ang-1 levels were slightly higher in women than men (p=0.025). In critical care patients, Ang-1 levels were weakly, inversely correlated with the severity of the illness as determined by SOFA scores (r=0.06, p=0.025), while ANG-2 levels were weakly, positively correlated with SOFA scores(r=0.426, p<0.0001). However, in critical care patients, neither protein was correlated with age or gender. Ang-2 levels showed more variability over the course of 24 h than Ang-1. Antibiotics did not affect Ang-1 or Ang-2 levels, but dialysis decreased Ang-1 and Ang-2 levels by 36.2 and 23.1%, respectively.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
    Other diagnoses
  • Platforms

    ProteinImmunoradiometric assay
    ProteinImmunoassay
    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Healthy control
    Intensive care patient (SOFA 3-22)
    PreaquisitionOther drugs
    Intravenous antibiotics
    PreaquisitionPatient age
    21-69 years
    PreaquisitionPatient body mass index
    19 to 32 kg/m2
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen AcquisitionTime of biospecimen collection
    0 h after IV antibiotics
    0.5 h after IV antibiotics
    1 h after IV antibiotics
    10 h after IV antibiotics
    12 h after IV antibiotics
    16 h after IV antibiotics
    2 h after IV antibiotics
    20 h after IV antibiotics
    24 h after IV antibiotics
    4 h after IV antibiotics
    6 h after IV antibiotics
    9 h after IV antibiotics
    After dialysis
    Before dialysis
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum
    StorageFreeze/thaw cycling
    0 cycles
    4 cycles
    StorageStorage duration
    0 h
    0.5 h
    1 h
    10 h
    12 h
    14 h
    16 h
    2 h
    20 h
    24 h
    4 h
    6 h
    8 h
    StorageStorage temperature
    4 degrees C
    Room temperature
    Immunoassay SpecificReaction solution
    Calcium supplemented buffer
    Regular buffer
    Immunoassay SpecificTechnology platform
    IRMA